Activity Survey
The APBMT Activity Survey has been performed since 2007.
The following figure shows how the data was collected.
The way of submission is different in each country/region.
From the countries/regions which have a national registry, data is submitted through the national registries. From the countries/regions which do not have a national registry, data is submitted through the regional persons in charge who collect data from major transplant centers or through major transplant centers directly.
- Activity Survey Form 2017 (for APBMT)
- Global Survey Form 2017 (for WBMT)
- Application form for using the Activity Survey Data :Members only; need ID, and Password
- Application form for using the Activity Survey Data :Members only; need ID, and Password
The result of Activity Survey 2018 (HSCT performed in 2016)
The No. of HSCTs are increasing year by year.
In 2016, that exceeded twenty-thousand in Asia - Pacific region.
20 countries and six-handred-eighty-six centers cooperated with our Activity Survey.
We appreciate about 40 cooperators made effort collecting this survey.
In 2016, Australia:1846, Bangladesh:12, China:5904, HongKong:142, India:1968, Iran:410, Japan:5488, Korea:2531, Malaysia:360, Mongolia:2, Myanmar:5, Nepal:5, NewZealand:305, Pakistan:146, Philippines:25, Singapore:210, SriLanka:5, Taiwan:543, Thailand:183, and Vietnam:81 HSCTs performed.
*Detailed of countries that no,of HSCT were under 1000 in 2016:Bangladesh, HongKong, Iran, Malaysia, Mongolia, Myanmar, Nepal, NewZealand, Pakistan, Philippines, Singapore, SriLanka, Taiwan, Thailand, and Vietnam.
The pie chart showing the Main indication of HSCTs in Asia-Pacific area.
AML accounts for more than 24 percent, Lymphoid malignancy: 19%, Plasma Cell Disorder: 17%, and ALL : 13%. These top 4 indication accounts three fourth of the whole.
The top 6 disease indications are AML, Lymphoid malignancy, Multiple Myeloma, ALL, MDS, and Aplastic anemia.
No. of Haplo transplant increased rapidly. In 2016, the number of them run up to 3,506.
Haplo transplant were performed in many countries.
In China and Philippines, Haplo transplant accounts for more than half of related transplant.
0.1-100 Bangladesh, China, India, Mongolia, Myanmar, Nepal, Pakistan, Philippines, Sri Lanka, Thailand, and Vietnam
100-300 Hong Kong, Iran, Malaysia, and Taiwan
300-500 South Korea, Singapore, and Japan
more than 500 Australia, and New Zealand
0.1-50 Bangladesh, China, India, Iran, Malaysia, Mongolia, Myanmar, Nepal, Pakistan, Philippines, Sri Lanka, Thailand, and Vietnam
50-150 Taiwan
150-200 Hong Kong, and Singapore
more than 200 Australia, Japan, New Zealand, and South Korea
0-1 Bangladesh, and Myanmar
1-50 China, Hong Kong, Iran, India, Mongolia, Nepal, Pakistan, Philippines, Sri Lanka, Thailand, and Vietnam
50-150 Japan, Malaysia, and Taiwan
150-300 Singapore, and South Korea
more than 300 Australia, and New Zealand
no UR Bangladesh, Mongolia, Myanmar, Nepal, Pakistan, Philippines, and Sri Lanka
0.01-10 China, Iran, India, Malaysia, Thailand, and Vietnam
10-50 Taiwan
50-100 Singapore, and Hong Kong
more than 100 Australia, Japan, New Zealand, and South Korea
Detailed information of APBMT Activity Survey 2016 (PDF). :Members only; need ID, and Password